NASDAQ
NovaBay Pharmaceuticals, Inc. (NBY) has a free cash flow growth of 20.70% as of Friday, May 29, 2026. This represents a 149.60% increase compared to its 12-month average of -41.74%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.